Chongqing Bioland Pharmaceutical Ltd. – FDA Inspection, Jan 17, 2025

Record Details

This FDA Inspection record concerns Chongqing Bioland Pharmaceutical Ltd., with an inspection on January 17, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Chongqing Bioland Pharmaceutical Ltd.
Inspection Date: January 17, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Jose F. Velez (Issuing Officer)

View Company Profile

ID · f84a2e62-8eb0-4119-9261-3eeb46ba80d1

Inspection Facts

Inspection number: 1259615
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Chongqing Bioland Pharmaceutical Ltd.

FDA Inspection

Chongqing Bioland Pharmaceutical Ltd.January 17, 2025

Chongqing Bioland Pharmaceutical Ltd. – FDA Inspection, Jan 17, 2025

Record Details

This FDA Inspection record concerns Chongqing Bioland Pharmaceutical Ltd., with an inspection on January 17, 2025, issued by the Office of Inspections and Investigations, covering human drugs.